ARMGO Pharma
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $35M
Investors
- 3
About ARMGO Pharma
Based in the US, ARMGO Pharma, Inc.ARMGO Pharma, Inc. specializes in developing therapeutics aimed at ryanodine receptors (RyRs) crucial for calcium flow and muscle function. Founded in 2004, the headquarters is located in the US. Gene Marcantonio serves as the CEO.RyCarma Therapeutics, a division of ARMGO Pharma, develops a novel class of therapeutics known as Rycals®, specifically targeting ryanodine receptors (RyRs) to regulate intracellular calcium flow and muscle contraction. Their lead candidate, Surlorian, addresses heart failure by enhancing cardiac and skeletal muscle cell function.RyCarma Therapeutics generates revenue through the development and commercialization of its flagship therapeutic, Surlorian. The company engages in B2B transactions with healthcare providers and research institutions, establishing partnerships for clinical trials and distribution.ARMGO Pharma, Inc. plans to further develop and launch new products within its Rycals® therapeutic line. The company is targeting expansion into new markets in Europe and North America by the end of 2025.
Who invested in ARMGO Pharma
3 investors across 1 round
See all investors in ARMGO Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Dec 20, 2021
Amount
$35M
Investors
Questions about ARMGO Pharma
Who invested in ARMGO Pharma?
ARMGO Pharma has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ARMGO Pharma raised?
ARMGO Pharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ARMGO Pharma last raise money?
ARMGO Pharma's most recent round on record is a Series B, in Dec 2021.
What does ARMGO Pharma do?
Based in the US, ARMGO Pharma, Inc.
Where is ARMGO Pharma headquartered?
ARMGO Pharma is headquartered in US.
Which VCs invest in companies like ARMGO Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ARMGO Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like ARMGO Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.